Improving chromatography for analysis of biological and pharmaceutical molecules: James Grinias, the 2022 winner of the Emerging Leader in Chromatography Award
Hear from James Grinias, the 2022 winner of the Emerging Leader in Chromatography Award
Hear from James Grinias, the 2022 winner of the Emerging Leader in Chromatography Award
With abundant data on plants, large animals and their activity, and carbon soil levels in the Amazon, Stanford research suggests that large animal diversity influences carbon stocks and contributes to climate change mitigation
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
New blood test provides a unique new framework for early detection of the most common cancers
Cancer epigeneticist, Dr. Sammy Ferri-Borgogno, of the MD Anderson Cancer Center, Texas, tells SelectScience® how live cell imaging reveals more information about pancreatic cancer cells while saving time and money
Convenient blood test uses novel technology to test for recurrence of tumors by detecting circulating DNA
Stanford researchers tease apart competing theories on how different species coexist.
Researchers aim to tackle the issue of plastic waste by enhancing pre-existing PETase – a known digestive enzyme for plastic materials
Meet the couple combining stroke research & Alzheimer’s expertise in the hope of understanding mixed dementia
Chromatography experts share how the latest 2D-LC technology can benefit your pharmaceutical, food, or polymer analysis applications and more
Panel of data science experts share their insights into how labs can ‘go digital’, and reveals a solution designed to help labs embrace digital advancements and go paperless
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies
Optical topography to reduce patient burden in the treatment of attention-deficit hyperactivity disorder
Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors
Orbitrap inventor Prof. Alexander Makarov and anti-doping expert Prof. Francisco Radler among the winners recognized during a ceremony at Pittcon 2017